Health-tech platform Lissun raises Rs 48 Cr in Series A led by Colossa Ventures
2 min read
Lissun secured Rs 48 crore in a Series A round led by Colossa Ventures, with additional backing from Physis Capital, RPSG Capital Ventures, IvyCap Ventures, Rainmatter (by Zerodha), Multiply Ventures, SucSEED Ventures, Beyond Capital Ventures and New Age India Fund.
Launched in 2021 by Krishna Veer Singh and Tarun Gupta, the company began as a mental‑health platform before shifting its emphasis to child development—a field where many families struggle to obtain prompt, specialised assistance.
Through its Sunshine by LISSUN division, Lissun now runs 25 centres that provide over 10,000 therapy sessions each month. According to co‑founder Krishna Veer Singh, the business has quadrupled in size over the last year, creating a solid foundation for further growth.
The fresh investment will enable the firm to open more centres nationwide, upgrade its clinical infrastructure and develop technology that assists therapists and parents. Lissun is also creating AI‑driven tools aimed at making care more personalised and efficient—not to replace therapists, but to help them monitor each child’s progress and deliver better ongoing support.
Parents often find it hard to locate reliable developmental care; children may need help with speech, behaviour, learning, communication or other challenges, yet specialised services are scarce nearby. Even when available, high fees, long wait times and limited awareness can hinder regular therapy.
Lissun’s approach tackles these obstacles by pairing physical centres with digital solutions. The centres offer direct, specialist‑led care, while online tools let therapists track progress and guide families between sessions, making support more organised and accessible.
The focus on child development also reflects a broader gap in India’s healthcare system. Growing awareness of developmental issues is prompting families to seek help earlier, but the supply of qualified professionals and quality centres remains limited. A responsibly scalable platform could reach more families without sacrificing care standards.
Looking ahead, Lissun faces both opportunity and responsibility. Expanding into new cities will demand trained staff, consistent clinical standards and thoughtful use of technology. The company must ensure that growth does not erode the personal attention children and families need.
With this Series A funding, Lissun now has the means to build on its early achievements. If it can blend human expertise with smart technology, it has the potential to become one of India’s leading child‑development platforms and bring specialised support to many more families.
About Author
